Introduction: Acyanotic congenital heart defect is a congenital structural abnormality arising from incomplete formation of the heart or major blood vessels which generally do not interfere with the amount of oxygen or blood that reaches the body's tissues so that cyanosis are rarely found in these patients. This research aims to evaluate the profile of acyanotic congenital heart defect patients in Paediatric Cardiology Outpatient Clinic Dr. Soetomo General Hospital Surabaya period of January – December 2016 based on 4 variables; gender, age, nutritional status, type of congenital heart disease and symptoms. Until 2017, the profile of acyanotic congenital heart defect in children in Outpatient Unit of Paediatrics Department Dr. Soetomo General Hospital Surabaya has not been much researched, so this research is expected to be used as learning reference for practitioners and other readers, and also as a reference in developing management strategies for children with acyanotic congenital heart defect in the future. Methods: This was a descriptive non-experimental study using cross-sectional design and was performed by evaluating medical record of acyanotic congenital heart defect patients in Department of Paediatrics Dr. Soetomo General Hospital Surabaya period of January – December 2016 and analysed using Microsoft Excel. Results: The results of this study revealed that majority of acyanotic congenital heart defect patients were female (53.85%) with age range between 0 – <5 years old. Atrial septal defect (ASD) was the most common type of acyanotic congenital heart defect (49.8%), with sign and symptom that is commonly found in patients were failure to thrive (61.94%). Majority of patients also suffered from growth disruption with most of patients aged 0 – <5 years old are severely underweight (42.46%) and most of patients aged 5 – 18 years old are having malnutrition (38.23%).

BACKGROUND: The COVID-19 pandemic determined a profound impact on the routine follow-up of type 1 diabetes (T1D) children. Telemedicine represents a critical tool to guarantee regular care for these patients in this form. AIM: The purpose of this study was to assess the impact of telemedicine programs during the COVID-19 pandemic era on T1D children. PATIENTS AND METHODS: Studies from PubMed, Cochrane, and Directory of Open Access Journals from December 2021, to February 18, 2022, were conducted to calculate the pooled mean difference using either a random or fixed-effect model in Review Manager version 5.3. Our study has applied to ensure that our procedures, including record collection, extraction of data, quality evaluation, and statistical analysis, adhere to the Preferred Reporting Items for Systematic Examination and Meta-Analysis guidelines. RESULTS: Three articles relevant to the current study (436 children). Our pooled analysis found that there was an impact of telemedicine in reducing the HbA1c (mean diff: 5.64 [95% confidence interval (CI) 3.71–7.57], p < 0.00001). However, the physical activity was not affected by the telemedicine program (mean diff: −37.25 [95% CI −317.53–243.02], p = 0.79). CONCLUSION: Our findings suggest that telemedicine has a role in T1D children controlling HbA1c during the COVID-19 pandemic. Meanwhile, telehealth has emerged as a promising alternate mode of health-care delivery. Its utility during the pandemic warrants further investigation.

Background: Stunting is chronic malnutrition associated with the risk of irreversible loss of cognitive function and stunting-related morbidity. Parental knowledge is essential in preventing stunting as it affects parenting patterns, child feeding practices, and the selection of food ingredients. Therefore, we aimed to analyze the improvement of public knowledge before and after given education about stunting. Methods: This descriptive study involved the community in the work area of the Driyorejo Public Health Center as the participants. We carried out community service in the form of health education about stunting and its prevention. Participants filled out a questionnaire before and after the intervention to evaluate the participants’ knowledge level. The demographic data, including gender, age, educational background, and occupation, are obtained using a self-reported questionnaire. Results: This study involved 85 participants consisting of 91.75% women with educational backgrounds, mostly having completed university (75.29%). The average score obtained before the intervention was 77.94, which increased to 87.35 after the intervention. The number of participants classified as having good knowledge increased from 58.82% to 83.53%, and the number of participants having poor knowledge decreased from 41.18% to 16.47% after the intervention. Conclusions: Health education done by health workers can significantly improve public understanding and increase public awareness about stunting. This emphasizes the important role of health workers as the spearhead in stunting prevention strategies.

The impact of the COVID-19 pandemic on glycemic control in Type 1 Diabetes Mellitus (T1DM) patients is still evolving. This study aims to assess the negative effect of the COVID-19 pandemic on mean glucose and glycated hemoglobin (HbA1c) in patients with T1DM. This meta-analysis study using the PRISMA framework method with the search strategy according to the population, intervention, control, and outcome (PICO) model. Relevant articles were searched in 4 databases. The results identified the HbA1c and mean glucose. The COVID-19 pandemic caused an increase in the HbA1c levels (%) compared to the pre-COVID group with a mean difference of -1.06 (95% CI: -1.44, -0.69; p<0.00001). Meanwhile, the mean glucose (mg/dL) decreased during-COVID-19 pandemic with a mean difference of -2.32 (95% CI: -4.40, -0.23; p=0.03). Ten studies with a total of 1615 subjects contributed for HbA1c analysis (during-COVID-19, n = 615; pre-COVID, n = 1000). A total of 1164 patients from six studies with a mean glucose analysis were included (during-COVID-19, n = 418; pre-COVID, n = 746). This study found that the COVID-19 pandemic significantly increased the levels of HbA1c and decreased mean glucose in patients with T1DM, but further studies need to be evaluated.

Young women with TS are susceptible to various medical complications, such as autoimmune disorders, overweight and obesity, and an increased risk of metabolic disorders, such as glucose intolerance or dyslipidemia and hypertension. This article presented the case of a 17-year-old girl with Turner syndrome, hypertension, insulin resistance, and obesity. This patient has been treated with Estradiol 1.5 mg every 24 hours for two months, continued with Microgynon 1 tablet daily for four months, Lisinopril 4 mg every 24 hours, and Metformin 250 mg every 8 hours and are advised to visit the Paediatric Endocrinology Polyclinic at Dr Soetomo Hospital once per month. After six months of treatment, the patient has a regular menstrual cycle and improved metabolic measurements. This paper highlighted the importance of early detection and prompt treatment of metabolic complications in Turner syndrome patients.